Modulators of cystic fibrosis transmembrane conductance regulator
US8604203B2 · kind B2 · utility
71Cited by
2References
35Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 15, 2012 |
| Grant date | Dec 10, 2013 |
| Priority date | — |
| Expiry date | Oct 15, 2032 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02P20/55
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to modulators of cystic fibrosis transmembrane conductance regulator (“CFTR”), compositions thereof, and methods therewith. The present invention also relates to methods of treating diseases using modulators of CFTR.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.